Ameritas Investment Partners’s Genesis Healthcare, Inc. GEN Stock Holding History

Ameritas Investment Partners’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,358	Closed	-$6K	–	3199
2020 Q1	$6K	Hold	7,358	–	–	﹤0.01%	2792
2019 Q4	$12K	Buy	7,358 +4,529	+160%	+$6.8K	﹤0.01%	2679
2019 Q3	$3K	Hold	2,829	–	–	﹤0.01%	3004
2019 Q2	$4K	Hold	2,829	–	–	﹤0.01%	2982
2019 Q1	$4K	Hold	2,829	–	–	﹤0.01%	2901
2018 Q4	$3K	Hold	2,829	–	–	﹤0.01%	2929
2018 Q3	$4K	Hold	2,829	–	–	﹤0.01%	2976
2018 Q2	$6K	Hold	2,829	–	–	﹤0.01%	2931
2018 Q1	$4K	Hold	2,829	–	–	﹤0.01%	2889
2017 Q4	$2K	Hold	2,829	–	–	﹤0.01%	2939
2017 Q3	$2K	Hold	2,829	–	–	﹤0.01%	2972
2017 Q2	$5K	Hold	2,829	–	–	﹤0.01%	2942
2017 Q1	$7K	Buy	+2,829	New	+$10.2K	﹤0.01%	2795

Other funds holding GEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameritas Investment Partners's GEN Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 7,358 shares — an estimated $6K sold.

Ameritas Investment Partners first reported a position in GEN in Q1 2017 and held it in 13 quarters. The position peaked at $12K in Q4 2019. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

Ameritas Investment Partners reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Partners sold 7,358 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $6K.
Ameritas Investment Partners first reported a position in Genesis Healthcare, Inc. in Q1 2017 and held it in 13 quarters.
Ameritas Investment Partners's Genesis Healthcare, Inc. position peaked at $12K in Q4 2019.
58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.